FDA — authorised 6 April 2000
- Application: NDA021086
- Marketing authorisation holder: CHEPLAPHARM
- Local brand name: ZYPREXA ZYDIS
- Indication: TABLET, ORALLY DISINTEGRATING — ORAL
- Status: approved
🇺🇸 Olanzapine OD Tablets 5 mg in United States
FDA authorised Olanzapine OD Tablets 5 mg on 6 April 2000
Marketing authorisation
Frequently asked questions
Is Olanzapine OD Tablets 5 mg approved in United States?
Yes. FDA authorised it on 6 April 2000.
Who is the marketing authorisation holder for Olanzapine OD Tablets 5 mg in United States?
CHEPLAPHARM holds the US marketing authorisation.